Targeting KRAS-driven tumours via their dependence on PTPN11/SHP2-phosphatase to enhance anti-tumour immunity (P17)

• Subject Area: Hematology, Oncology ; General and Visceral Surgery ; Rheumatology
• Term: since 2021
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 441891347

No abstract available

• DFG Programme: Collaborative Research Centres
• Subproject of: SFB 1479: Oncogene-driven immune escape (OncoEscape)
• Applicant Institution: Albert-Ludwigs-Universität Freiburg
• Project Head: Privatdozent Dr. Dietrich Ruess